Skip to content
Brand AI

HistoSonics

Request correction

Corporate brand

Unclaimed

HistoSonics is a company that has developed a non-invasive, sonic beam therapy platform using histotripsy to destroy targeted liver tumors.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

HistoSonics is a company that has developed a non-invasive, sonic beam therapy platform that uses histotripsy, which is capable of destroying targeted liver tumors at a sub-cellular level. The science of histotripsy was developed by leading ultrasound scientists from the University of Michigan. The company collaborates with clinicians from the University of Wisconsin and the University of Michigan to bring histotripsy into clinical practice.

History

HistoSonics has developed a non-invasive, sonic beam therapy platform that uses histotripsy, which is capable of destroying targeted liver tumors at a sub-cellular level. The science of histotripsy was developed by leading ultrasound scientists from the University of Michigan. Leading multi-disciplinary clinicians from the University of Wisconsin and the University of Michigan collaborate through ongoing partnerships with HistoSonics to bring histotripsy into everyday clinical practice.

Recent events

  • Reported

    HistoSonics appoints Joe Amaral as vice president of medical affairs[4]

    HistoSonics announced the appointment of Joe Amaral, MD, to the newly created position of vice president of medical affairs, where he will oversee global clinical development initiatives.

Read more

Sources4 sources

  1. 1HistoSonics | Leader in Histotripsyhistosonics.com
  2. 2About Us | HistoSonicshistosonics.com
  3. 3HistoSonics, Inc. (United States)wikidata.org
  4. 4HistoSonics 任命 Joe Amaral 为医疗事务副总裁prnewswire.com

Cite this profile: Cite the canonical profile. /brand-wiki/histosonics · Editorial policy · How profiles are compiled